Dr Reddys Laboratories (RDY) Cash & Current Investments (2017 - 2026)
Dr Reddys Laboratories has reported Cash & Current Investments over the past 10 years, most recently at $235.1 million for Q1 2026.
- For Q1 2026, Cash & Current Investments rose 27.72% year-over-year to $235.1 million; the TTM value through Mar 2026 reached $235.1 million, up 27.72%, while the annual FY2026 figure was $235.1 million, 31.34% up from the prior year.
- Cash & Current Investments for Q1 2026 was $235.1 million at Dr Reddys Laboratories, up from $184.1 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $751.8 million in Q1 2023 and troughed at $87.6 million in Q1 2024.
- A 5-year average of $296.3 million and a median of $222.9 million in 2022 define the central range for Cash & Current Investments.
- Biggest five-year swings in Cash & Current Investments: soared 237.31% in 2023 and later plummeted 88.35% in 2024.
- Year by year, Cash & Current Investments stood at $222.9 million in 2022, then soared by 237.31% to $751.8 million in 2023, then plummeted by 88.35% to $87.6 million in 2024, then skyrocketed by 110.1% to $184.1 million in 2025, then grew by 27.72% to $235.1 million in 2026.
- Business Quant data shows Cash & Current Investments for RDY at $235.1 million in Q1 2026, $184.1 million in Q1 2025, and $87.6 million in Q1 2024.